Anup Barde
About Anup Barde
Anup Barde is a Director of Chemistry at Integral BioSciences Pvt. Ltd., where he leads the scale-up group. He has extensive experience in compound scale-up and has previously held senior roles at various pharmaceutical companies, including Sai Life Sciences and Emcure Pharmaceuticals.
Current Role at Integral BioSciences Pvt. Ltd.
Anup Barde serves as the Director of Chemistry at Integral BioSciences Pvt. Ltd. since May 2013. In this role, he leads the scale-up group, focusing on the transition of chemical compounds from gram scale to larger manufacturing processes. His responsibilities include overseeing the technology transfer necessary for efficient production. Barde's extensive background in chemistry and experience in the pharmaceutical industry contribute to his leadership in this capacity.
Previous Experience in Pharmaceutical Industry
Anup Barde has held several significant positions in the pharmaceutical sector. He worked at Sai Life Sciences Ltd. as Senior Director of Chemistry from 2007 to 2013, and briefly as Sr. Director in 2012. Prior to that, he was a Manager in R&D at Emcure Pharmaceuticals from 2003 to 2007. His career also includes roles at USV Limited and FDC Limited, where he gained valuable experience in chemical process research and development.
Educational Background in Chemistry
Anup Barde has a robust educational background in chemistry. He completed his Bachelor's degree in Chemistry at D.G. Ruparel College, Mumbai from 1987 to 1990. He then pursued a Master's degree in Organic Chemistry at the same institution, graduating in 1992. Barde further advanced his studies by earning a PhD in Organic Chemistry from Haffkine Institute, Mumbai, in 1996. This academic foundation supports his extensive expertise in the field.
Expertise in Scale-Up and Regulatory Compliance
Anup Barde possesses extensive experience in the scale-up of chemical compounds, transitioning them from laboratory settings to large-scale manufacturing. He has supported Drug Master File (DMF) filings for several Active Pharmaceutical Ingredients (APIs) and has played a role in Pre-Approval Inspections for US-FDA approval. His knowledge in regulatory compliance is critical to his current role and previous positions in the pharmaceutical industry.